Bravo pH Monitoring for Acid Reflux

(PROPER-GERD Trial)

This trial aims to evaluate the effectiveness of a special pH monitoring device for diagnosing gastroesophageal reflux disease (GERD), which causes symptoms like heartburn and chest discomfort. Researchers will use the Bravo pH monitoring system, inserting two small probes to measure acid levels in the esophagus when symptoms occur. Participants will also maintain a diary of their symptoms for four days. This trial suits adults who experience typical GERD symptoms and have not undergone previous stomach or esophagus surgeries. As an unphased trial, it offers participants the chance to contribute to valuable research that could enhance GERD diagnosis.

Research has shown that the Bravo pH Monitoring System is very safe. Studies have found it to be a reliable method for checking acid levels in the esophagus. Most people find it easy to use and tolerate well. Some might experience a slight sensation in the chest or discomfort when swallowing, but these effects are usually mild. Overall, the Bravo system offers a more comfortable option compared to older tube-based methods, making it a good choice for confirming gastroesophageal reflux disease (GERD).¹²³⁴⁵

Researchers are excited about the Bravo pH monitoring sessions for acid reflux because they offer a unique way to measure acid levels in the esophagus. Unlike traditional methods that typically involve a single probe placed higher in the esophagus, this new approach uses two probes, with one positioned just 1 cm above the stomach junction. This closer placement allows for more precise monitoring of acid exposure, which could lead to more accurate diagnoses and better tailored treatments for individuals with acid reflux. By improving the precision of acid measurements, this technique has the potential to enhance the understanding of acid reflux patterns and improve patient outcomes.

Research has shown that Bravo pH monitoring effectively diagnoses gastroesophageal reflux disease (GERD) by measuring acid levels in the esophagus. Studies indicate it can track data for 48 to 96 hours, surpassing traditional methods. This extended monitoring period helps accurately identify acid reflux patterns, improving the chances of detecting GERD symptoms and leading to a more reliable diagnosis. In this trial, participants will undergo one Bravo pH monitoring session with two simultaneous probes, including an experimental probe placement. The test is minimally invasive, making it easier for patients to handle. Overall, it serves as a valuable tool for confirming GERD and assessing its severity.¹⁴⁶⁷⁸